Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Migraine Market Update: CGRP Inhibitors Slowly Gain Ground
New Medicines For The Condition More Than Doubled This Year
Sep 07 2020
•
By
Mandy Jackson
Seven migraine drugs have been approved since 2018; four launched this year • Source: Shutterstock
More from Market Snapshot
More from Scrip